MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
As of January 02, 2026, HEICO Corporation had a $39.8 billion market capitalization, putting it in the 92nd percentile of companies in the Aerospace & Defense industry. Currently, HEICO Corporation’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback